Sionna Therapeutics (SION): Assessing Valuation After a Rapid 95% 3-Month Share Price Surge [Yahoo! Finance]
Sionna Therapeutics, Inc. (SION)
Company Research
Source: Yahoo! Finance
See our latest analysis for Sionna Therapeutics. Momentum has definitely built for Sionna Therapeutics, with a strong 1-month share price return of 20.7% and an even more impressive 3-month gain close to 95%. After this surge, the latest share price sits at $34.4, reminding investors how quickly sentiment can shift when growth potential comes into focus. If you want to see what other biotech names are generating buzz, take your next step by exploring our See the full list for free. With shares already nearing analyst price targets after outsized gains, the key question is whether the remarkable rally leaves further upside on the table, or if the market has already priced in Sionna's future growth prospects. Price-to-Book of 4.7: Is it justified? Sionna Therapeutics trades at a price-to-book ratio of 4.7, slightly higher than its biotech peer average. This suggests investors are paying a premium for its potential. The price-to-book ratio compares a company's market value t
Show less
Read more
Impact Snapshot
Event Time:
SION
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SION alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SION alerts
High impacting Sionna Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
SION
News
- Sionna Therapeutics Valuation Topping $2 Billion Is 'Too Optimistic', RBC Says [Yahoo! Finance]Yahoo! Finance
- Sionna Therapeutics (NASDAQ:SION) had its "underperform" rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $24.00 price target on the stock.MarketBeat
- Sionna Therapeutics to Participate in Upcoming December Investor ConferencesGlobeNewswire
- Sionna Therapeutics (NASDAQ:SION) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Sionna Therapeutics (NASDAQ:SION) was upgraded by analysts at BTIG Research to a "strong-buy" rating.MarketBeat
SION
Earnings
- 11/5/25 - Beat
SION
Sec Filings
- 12/5/25 - Form 144
- 11/26/25 - Form 4
- 11/26/25 - Form 4
- SION's page on the SEC website